Sutro Biopharma, Inc. (STRO)
9.33
-0.96
(-9.33%)
USD |
NASDAQ |
Oct 23, 16:00
9.335
0.00 (0.00%)
After-Hours: 20:00
Sutro Biopharma Price to Book Value
Price to Book Value Chart
Historical Price to Book Value Data
| Date | Value |
|---|---|
| March 28, 2025 | 1.364 |
| March 27, 2025 | 1.369 |
| March 26, 2025 | 1.416 |
| March 25, 2025 | 1.388 |
| March 24, 2025 | 1.425 |
| March 21, 2025 | 1.419 |
| March 20, 2025 | 1.473 |
| March 19, 2025 | 1.519 |
| March 18, 2025 | 1.658 |
| March 17, 2025 | 1.725 |
| March 14, 2025 | 1.499 |
| March 13, 2025 | 2.313 |
| March 12, 2025 | 2.479 |
| March 11, 2025 | 2.368 |
| March 10, 2025 | 2.498 |
| March 07, 2025 | 2.776 |
| March 06, 2025 | 2.72 |
| March 05, 2025 | 2.516 |
| March 04, 2025 | 2.628 |
| March 03, 2025 | 2.655 |
| February 28, 2025 | 2.942 |
| February 27, 2025 | 2.868 |
| February 26, 2025 | 2.979 |
| February 25, 2025 | 3.053 |
| February 24, 2025 | 3.164 |
| Date | Value |
|---|---|
| February 21, 2025 | 3.275 |
| February 20, 2025 | 3.386 |
| February 19, 2025 | 3.460 |
| February 18, 2025 | 3.460 |
| February 14, 2025 | 3.312 |
| February 13, 2025 | 3.220 |
| February 12, 2025 | 2.979 |
| February 11, 2025 | 3.007 |
| February 10, 2025 | 3.312 |
| February 07, 2025 | 3.682 |
| February 06, 2025 | 3.923 |
| February 05, 2025 | 3.756 |
| February 04, 2025 | 3.682 |
| February 03, 2025 | 3.516 |
| January 31, 2025 | 3.553 |
| January 30, 2025 | 3.608 |
| January 29, 2025 | 3.479 |
| January 28, 2025 | 3.516 |
| January 27, 2025 | 3.682 |
| January 24, 2025 | 3.775 |
| January 23, 2025 | 3.756 |
| January 22, 2025 | 3.645 |
| January 21, 2025 | 3.682 |
| January 17, 2025 | 3.719 |
| January 16, 2025 | 3.423 |
Price to Book Ratio Definition
Price to book value is a valuation ratio that is measured by stock price / book value per share. The book value is essentially the tangible accounting value of a firm compared to the market value that is shown.
Price to Book Value Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Price to Book Value Benchmarks
| Upstream Bio, Inc. | 0.5539 |
| ACADIA Pharmaceuticals, Inc. | 2.599 |
| Alnylam Pharmaceuticals, Inc. | 22.13 |
| Anika Therapeutics, Inc. | 2.088 |
| Savara, Inc. | 6.034 |
Price to Book Value Related Metrics
| PS Ratio | 2.385 |
| PEG Ratio | -0.0108 |
| Price | 9.33 |
| Earnings Yield | -186.6% |
| Market Cap | 154.66M |
| PEGY Ratio | -0.0108 |